Deprecated: Creation of dynamic property Smush\Core\Modules::$webp is deprecated in /home4/wherejj3/public_html/gentta/wp-content/plugins/wp-smushit/core/class-modules.php on line 109

Deprecated: Creation of dynamic property Smush\Core\Modules\Helpers\Parser::$iframes is deprecated in /home4/wherejj3/public_html/gentta/wp-content/plugins/wp-smushit/core/modules/helpers/class-parser.php on line 79

Deprecated: Creation of dynamic property ET_Bloom::$plugin_class_name is deprecated in /home4/wherejj3/public_html/gentta/wp-content/plugins/bloom/dashboard/dashboard.php on line 41

Deprecated: Creation of dynamic property ET_Bloom::$save_button_text is deprecated in /home4/wherejj3/public_html/gentta/wp-content/plugins/bloom/dashboard/dashboard.php on line 42

Deprecated: Creation of dynamic property ET_Bloom::$options_path is deprecated in /home4/wherejj3/public_html/gentta/wp-content/plugins/bloom/dashboard/dashboard.php on line 44

Deprecated: Creation of dynamic property ET_Bloom::$top_level_page is deprecated in /home4/wherejj3/public_html/gentta/wp-content/plugins/bloom/dashboard/dashboard.php on line 45

Deprecated: Creation of dynamic property ET_Bloom::$dashboard_options is deprecated in /home4/wherejj3/public_html/gentta/wp-content/plugins/bloom/dashboard/dashboard.php on line 48

Deprecated: Creation of dynamic property ET_Bloom::$dashboard_sections is deprecated in /home4/wherejj3/public_html/gentta/wp-content/plugins/bloom/dashboard/dashboard.php on line 93

Deprecated: Creation of dynamic property ET_Bloom::$assigned_options is deprecated in /home4/wherejj3/public_html/gentta/wp-content/plugins/bloom/dashboard/dashboard.php on line 94

Deprecated: Creation of dynamic property ET_Bloom::$provider_names is deprecated in /home4/wherejj3/public_html/gentta/wp-content/plugins/bloom/dashboard/dashboard.php on line 95

Deprecated: Creation of dynamic property DGbc_BlogCarousel::$icon_path is deprecated in /home4/wherejj3/public_html/gentta/wp-content/themes/Divi/includes/builder/class-et-builder-element.php on line 1425
Good News Friday – Vaccines Success Stories - GENTTA
Select Page
GOOD NEWS FRIDAY'S 4MIN ACTION

vaccines Success Stories

It’s been a long week. It’s time for some GOOD NEWS!

As part of its ‘vaccine diplomacy’ campaign, India plans to offer 20 million vaccines to Nepal, Bhutan, Sri Lanka, Myanmar, Bangladesh, Afghanistan, the Maldives, and Mauritius, with many of these aid shipments being completely free. Good News Network

WHAT CAN YOU DO IN 4 MINUTES?

Read these articles and feel better about life!

Only have 4 minutes – check out our highlights
Got more time – read more than one!

10 Positive COVID Updates From Around the World – 2021 is Looking Brighter  Good News Network

 

Showcasing a Canadian success story: The Ebola vaccine – Canadian Institutes of Health Research 

 

Healthcare Workers Stuck in Snowy Traffic With Expiring COVID Vaccines Go Car to Car Offering Them to Drivers – Good News Network


Same Technology Behind Pfizer COVID-19 Vaccine is Leading Researchers to Possible MS Breakthrough – Good News Network
 

Our Article Highlights

REFERENCES

10 Positive COVID Updates From Around the World – 2021 is Looking Brighter  Good News Network

 

Showcasing a Canadian success story: The Ebola vaccine – Canadian Institutes of Health Research 

 

Healthcare Workers Stuck in Snowy Traffic With Expiring COVID Vaccines Go Car to Car Offering Them to Drivers – Good News Network

Same Technology Behind Pfizer COVID-19 Vaccine is Leading Researchers to Possible MS Breakthrough – Good News Network 

 

WHAT?

News and current events can be depressing!

GOAL

Good News Friday will lift our spirits and take us into a great weekend!

 

    WHO?

    Anyone who pays attention to current affairs cares about the environment, social services, democracy, fairness, the truth…

    SOLUTION

    Every Friday, instead of focusing on the negative and on the things we want to change, we focus on what’s already good in the world and spend time learning and sharing this news.

    The same technology behind Pfizer COVID-19 vaccine is leading researchers to a possible MS breakthrough. Good News Network

    Highlights

    Medical schools are being inundated with applications from those who want to join the field. The number of students applying to medical school for the upcoming 2021 academic year is up by 18%.

    The six lucky people who got the unexpected shot in the arm were elated. One “vaccinatee” was so psyched, he jumped out of his car and stripped off his shirt in the blizzard to get his injection.

    BioNTech, the German firm which together with Pfizer created one of the COVID-19 vaccines, says they have used the same technology to create a vaccine which delayed the onset and reduced the severity of multiple sclerosis (MS) in mice.

    CIHR joined forces with PHAC and the Canadian Immunization Research Network (CIRN), located in Halifax, to conduct a Phase I clinical trial of the Ebola vaccine, on local residents. “CIRN has an excellent reputation and features an emergency rapid response infrastructure,” said Dr. Ouellette. “This facilitates the fast application, peer review, approval, and funding of clinical trials.” The first step for CIRN was to ask healthy volunteers to participate. The public response was extraordinary.